U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday.

But President Donald Trump dismissed the assessment of U.S. spy agencies during an overnight flight back to Washington as he ...

Another year, another edition of Battle 4 The Bay. Five Morning Journal coverage area teams participated in the two-day event ...